Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
TIRANUS
Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)
- NCT05661188 ↗
- Completed
- Grupo Espanol Multidisciplinario del Cancer Digestivo
- Focused
We haven't built an HCP commentary report on TIRANUS (tiragolumab plus atezolizumab in localized anal canal squamous cell carcinoma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on TIRANUS so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 2 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- Phase II Study of Atezolizumab Plus Tiraglolumab in Combination With Chemoradiotherapy in Localized Squamous Cell Carcinoma of the Anal Canal
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Squamous Cell Carcinoma of the Anal Canal
- Interventions
- Atezolizumab plus Tiraglolumab
- Arms
- atezolizumab and tiragolumab in concomitancy with standard chemoradiotherapy · Experimental
- Enrollment
- 45
- Primary outcomes
- Clinical complete response (CCR)
- Clinical complete response (CCR) rate
- Sponsor
- Grupo Espanol Multidisciplinario del Cancer Digestivo with Hoffmann-La Roche
- Start
- Feb 14, 2023
- Primary completion
- Sep 25, 2026
- Results posted
- No
- Registry record
- NCT05661188 · updated Oct 7, 2026